Preparing for the Next Influenza Pandemic: The Development of a Universal Influenza Vaccine.
作者信息
Crank Michelle C, Mascola John R, Graham Barney S
机构信息
Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland.
出版信息
J Infect Dis. 2019 Apr 8;219(Suppl_1):S107-S109. doi: 10.1093/infdis/jiz043.
Abstract
摘要
相似文献
1
Preparing for the Next Influenza Pandemic: The Development of a Universal Influenza Vaccine.为下一次流感大流行做准备：通用流感疫苗的研发。
J Infect Dis. 2019 Apr 8;219(Suppl_1):S107-S109. doi: 10.1093/infdis/jiz043.
2
How Live Attenuated Vaccines Can Inform the Development of Broadly Cross-Protective Influenza Vaccines.减毒活疫苗如何为广泛交叉保护性流感疫苗的研发提供信息。
J Infect Dis. 2019 Apr 8;219(Suppl_1):S81-S87. doi: 10.1093/infdis/jiy703.
3
Neuraminidase, the Forgotten Surface Antigen, Emerges as an Influenza Vaccine Target for Broadened Protection.神经氨酸酶，被遗忘的表面抗原，作为流感疫苗靶点出现，以实现更广泛的保护。
J Infect Dis. 2019 Apr 8;219(Suppl_1):S75-S80. doi: 10.1093/infdis/jiz017.
4
Influenza Vaccines: Good, but We Can Do Better.流感疫苗：效果良好，但我们可以做得更好。
J Infect Dis. 2019 Apr 8;219(Suppl_1):S1-S4. doi: 10.1093/infdis/jiy633.
5
Making Universal Influenza Vaccines: Lessons From the 1918 Pandemic.研发通用流感疫苗：从 1918 年大流感中汲取的教训。
J Infect Dis. 2019 Apr 8;219(Suppl_1):S5-S13. doi: 10.1093/infdis/jiy728.
6
Development of live attenuated influenza vaccines against pandemic influenza strains.针对大流行性流感毒株的减毒活流感疫苗的研发。
Expert Rev Vaccines. 2014 Jul;13(7):855-71. doi: 10.1586/14760584.2014.922417. Epub 2014 May 28.
7
Antigenic and genetic characteristics of zoonotic influenza viruses and development of candidate vaccine viruses for pandemic preparedness.人畜共患流感病毒的抗原和基因特征以及大流行防范候选疫苗病毒的研发。
Wkly Epidemiol Rec. 2015 Oct 16;90(42):561-71.
8
Universal Influenza Vaccine Approaches Using Full-Length or Head-Only Hemagglutinin Proteins.通用流感疫苗的全长或仅头部血凝素蛋白方法。
J Infect Dis. 2019 Apr 8;219(Suppl_1):S57-S61. doi: 10.1093/infdis/jiz004.
9
Antigenic and genetic characteristics of zoonotic influenza viruses and development of candidate vaccine viruses for pandemic preparedness.人畜共患流感病毒的抗原和基因特征以及大流行防范候选疫苗病毒的研发。
Wkly Epidemiol Rec. 2012 Oct 19;87(42):401-12.
10
Antigenic and genetic characteristics of zoonotic influenza viruses and development of candidate vaccine viruses for pandemic preparedness.人畜共患流感病毒的抗原和基因特征以及大流行防范候选疫苗病毒的研发。
Wkly Epidemiol Rec. 2012 Mar 16;87(11):97-108.
引用本文的文献
1
Evaluating the Public Health and Health Economic Impacts of Baloxavir Marboxil and Oseltamivir for Influenza Pandemic Control in China: A Cost-Effectiveness Analysis Using a Linked Dynamic Transmission-Economic Evaluation Model.评估巴洛沙韦玛波西利和奥司他韦在中国流感大流行控制中的公共卫生和健康经济影响：使用关联动态传播-经济评估模型的成本效益分析。
Pharmacoeconomics. 2024 Oct;42(10):1111-1125. doi: 10.1007/s40273-024-01412-9. Epub 2024 Jul 3.
2
Heterologous prime-boost H1N1 vaccination exacerbates disease following challenge with a mismatched H1N2 influenza virus in the swine model.在猪模型中，异源初免-加强 H1N1 疫苗接种会加剧与不匹配的 H1N2 流感病毒攻击后的疾病。
Front Immunol. 2023 Oct 20;14:1253626. doi: 10.3389/fimmu.2023.1253626. eCollection 2023.
3
Recent Progress in Recombinant Influenza Vaccine Development Toward Heterosubtypic Immune Response.近年来重组流感疫苗研发取得进展，以实现针对不同亚型的免疫应答。
Front Immunol. 2022 May 19;13:878943. doi: 10.3389/fimmu.2022.878943. eCollection 2022.
4
A comprehensive influenza reporter virus panel for high-throughput deep profiling of neutralizing antibodies.用于中和抗体高通量深度分析的综合性流感报告病毒组。
Nat Commun. 2021 Mar 19;12(1):1722. doi: 10.1038/s41467-021-21954-2.
本文引用的文献
1
Influenza Vaccines: Good, but We Can Do Better.流感疫苗：效果良好，但我们可以做得更好。
J Infect Dis. 2019 Apr 8;219(Suppl_1):S1-S4. doi: 10.1093/infdis/jiy633.
2
Dynamic Perspectives on the Search for a Universal Influenza Vaccine.对通用流感疫苗的探索的动态观点。
J Infect Dis. 2019 Apr 8;219(Suppl_1):S46-S56. doi: 10.1093/infdis/jiz044.
3
How Live Attenuated Vaccines Can Inform the Development of Broadly Cross-Protective Influenza Vaccines.减毒活疫苗如何为广泛交叉保护性流感疫苗的研发提供信息。
J Infect Dis. 2019 Apr 8;219(Suppl_1):S81-S87. doi: 10.1093/infdis/jiy703.
4
Universal Influenza Vaccine Approaches Using Full-Length or Head-Only Hemagglutinin Proteins.通用流感疫苗的全长或仅头部血凝素蛋白方法。
J Infect Dis. 2019 Apr 8;219(Suppl_1):S57-S61. doi: 10.1093/infdis/jiz004.
5
The Way Forward: Potentiating Protective Immunity to Novel and Pandemic Influenza Through Engagement of Memory CD4 T Cells.向前之路：通过记忆 CD4 T 细胞的参与增强对新型和大流行性流感的保护性免疫。
J Infect Dis. 2019 Apr 8;219(Suppl_1):S30-S37. doi: 10.1093/infdis/jiy666.
6
Antibody Determinants of Influenza Immunity.流感免疫的抗体决定簇。
J Infect Dis. 2019 Apr 8;219(Suppl_1):S21-S29. doi: 10.1093/infdis/jiz010.
7
Predicting the Next Influenza Pandemics.预测下一次流感大流行。
J Infect Dis. 2019 Apr 8;219(Suppl_1):S14-S20. doi: 10.1093/infdis/jiz040.
8
The Role of Matrix Protein 2 Ectodomain in the Development of Universal Influenza Vaccines.基质蛋白 2 胞外结构域在通用流感疫苗开发中的作用。
J Infect Dis. 2019 Apr 8;219(Suppl_1):S68-S74. doi: 10.1093/infdis/jiz003.
9
New Vaccine Design and Delivery Technologies.新型疫苗设计与传递技术。
J Infect Dis. 2019 Apr 8;219(Suppl_1):S88-S96. doi: 10.1093/infdis/jiy745.
10
Neuraminidase, the Forgotten Surface Antigen, Emerges as an Influenza Vaccine Target for Broadened Protection.神经氨酸酶，被遗忘的表面抗原，作为流感疫苗靶点出现，以实现更广泛的保护。
J Infect Dis. 2019 Apr 8;219(Suppl_1):S75-S80. doi: 10.1093/infdis/jiz017.
Zotero 插件